How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

233 results for

Eagles Cardiac Risk Assessment

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Eagle's Cardiac Risk Assessment

Eagle's Cardiac Risk Assessment Eagles Cardiac Risk Assessment Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Eagle's Cardiac Risk (...) Assessment Eagle's Cardiac Risk Assessment Aka: Eagle's Cardiac Risk Assessment II. Risk Factors: Major Cardiovascular Risks - Unstable Coronary Syndromes Recent (Within 30 days) or severe ( 3-4) Decompensated Severe valvular disease Severe (mean gradient >40 mm Hg, area <1 cm) Symptomatic Significant arrhythmia High grade Mobitz II Symptomatic ventricular arrhythmia Uncontrolled rate in supraventricular arrhythmia with >100 III. Risk Factors: Intermediate Cardiovascular Risks Mild ( 1-2) Prior

2018 FP Notebook

2. ACP Preoperative Cardiac Risk Assessment

Preoperative Cardiac Risk Assessment ACP Preoperative Cardiac Risk Assessment Aka: ACP Preoperative Cardiac Risk Assessment II. Background Replaced by Listed for historical reasons only III. Criteria: Eagle and Vanzetto Age over 70 years Q waves on ECG History of History of History of ventricular ectopy History of ST segment abnormalities on EKG with IV. Protocol Indications for surgery without further evaluation Young healthy patient undergoing minor surgery Noncardiac emergency surgery Class I Risk Index (...) ACP Preoperative Cardiac Risk Assessment ACP Preoperative Cardiac Risk Assessment Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 ACP

2018 FP Notebook

3. ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

is to endorse a standardized and evidence-based ap- proach to perioperative cardiac management. The Guidelines recom- mend a practical, stepwise evaluation of the patient that integrates clinical risk factors and test results with the estimated stress of the planned surgical procedure. This results in an individualized cardiac risk assessment, with the opportunity of initiating medical therapy, cor- onary interventions, and speci?c surgical and anaesthetic techniques in order to optimize the patient’s (...) - operative cardiac risk assessment and is measured in metabolic equivalents (METs). One MET equals the basal metabolic rate. Ex- ercise testing provides an objective assessment of functional cap- acity. Without testing, functional capacity can be estimated from the ability to perform the activities of daily living. One MET repre- sents metabolic demand at rest; climbing two ?ights of stairs demands 4 METs, and strenuous sports, such as swimming,.10 METS (Figure 1). The inability to climb two ?ights

Full Text available with Trip Pro

2014 European Society of Cardiology

4. Eagle's Cardiac Risk Assessment

Eagle's Cardiac Risk Assessment Eagles Cardiac Risk Assessment Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Eagle's Cardiac Risk (...) Assessment Eagle's Cardiac Risk Assessment Aka: Eagle's Cardiac Risk Assessment II. Risk Factors: Major Cardiovascular Risks - Unstable Coronary Syndromes Recent (Within 30 days) or severe ( 3-4) Decompensated Severe valvular disease Severe (mean gradient >40 mm Hg, area <1 cm) Symptomatic Significant arrhythmia High grade Mobitz II Symptomatic ventricular arrhythmia Uncontrolled rate in supraventricular arrhythmia with >100 III. Risk Factors: Intermediate Cardiovascular Risks Mild ( 1-2) Prior

2015 FP Notebook

5. 2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

quality of life and ability to return to work more quickly. One observational study within a community demonstrated a 10-year absolute risk reduction in all-cause mortality of >12% in patients with CABG who participated in a CR program. Studies have also found that CR participation is associated with a 20% to 30% reduction in hospital readmission during the year after a cardiac event. Even with the underlying evidence demonstrating the benefits of CR, most eligible patients are still not receiving (...) With ST-Elevation Myocardial Infarction 4. 2013 ACCF/AHA Guideline for the Management of Heart Failure 5. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk 6. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease 7. Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update: a guideline from the American Heart Association 8. AHA/ACCF Secondary Prevention and Risk Reduction

2018 American Heart Association

6. Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association

Myopathies Because of the inherent genetic heterogeneity among the group of neuromuscular disorders known as MFM, the risk and type of cardiac involvement vary substantially. Cardiomyopathy with MFM can manifest as dilated, hypertrophic, restrictive, or LVNC phenotypes. As with other NMDs, referral to a cardiologist for cardiac assessment should begin with the initial diagnosis. For individuals with poor echocardiographic images, CMR should be considered. Although CMR is more sensitive for detection (...) . In this statement, we provide background on several NMDs in which there is cardiac involvement, highlighting unique features of NMD-associated myocardial disease that require clinicians to tailor their approach to prevention and treatment of heart failure. Undoubtedly, further investigations are required to best inform future guidelines on NMD-specific cardiovascular health risks, treatments, and outcomes. Neuromuscular diseases (NMDs) encompass a broad spectrum of diagnoses with overlapping but distinct

Full Text available with Trip Pro

2017 American Heart Association

7. ACP Preoperative Cardiac Risk Assessment

Preoperative Cardiac Risk Assessment ACP Preoperative Cardiac Risk Assessment Aka: ACP Preoperative Cardiac Risk Assessment II. Background Replaced by Listed for historical reasons only III. Criteria: Eagle and Vanzetto Age over 70 years Q waves on ECG History of History of History of ventricular ectopy History of ST segment abnormalities on EKG with IV. Protocol Indications for surgery without further evaluation Young healthy patient undergoing minor surgery Noncardiac emergency surgery Class I Risk Index (...) ACP Preoperative Cardiac Risk Assessment ACP Preoperative Cardiac Risk Assessment Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 ACP

2015 FP Notebook

8. Effect of Different Types of Anesthesia on Perioperative Brain Natriuretic Peptide Levels in Parturient Cardiac Patient Undergoing Elective Cesarean Section

, in relation to type of anesthesia used, general anesthesia versus spinal anesthesia, in order to evaluate the safety of type of anesthesia used for this kind of patient. It is very important to assess and predict risk in the cardiovascular system in such cases. A number of cardiac indexes for predicting risk have been developed like Goldman Multifactorial risk index, Eagle's risk index and Detsky's cardiac index. It is recommended to evaluate patients using these indexes and to institute preoperative (...) hormone levels preoperatively and postoperatively in parturient cardiac patient undergoing cesarean section Condition or disease Intervention/treatment General Anesthesia Versus Spinal Anesthesia on BNP Hormone Levels Preoperatively and Postoperatively in Parturient Cardiac Patient Undergoing C.S Diagnostic Test: G.A Group A: Detailed Description: In our study, investigators will detect changes in brain natruretic peptide (BNP) levels in parturient patients at risk undergoing cesarean section

2018 Clinical Trials

9. Impact of Percutaneous Coronary Intervention Performance Reporting on Cardiac Resuscitation Centers

on Cardiopulmonary, Critical Care, Perioperative and Resuscitation Originally published 15 Jul 2013 Circulation. 2013;128:762–773 You are viewing the most recent version of this article. Previous versions: Introduction Patients who experience out-of-hospital cardiac arrest (OHCA) have high mortality rates. Acute coronary occlusions and high-risk coronary obstructive disease are common in this population, especially in patients with ventricular tachycardia or ventricular fibrillation (VF) as the presenting (...) of coma. In addition, there is increasing evidence that patients without evidence of STEMI on a presenting ECG may also benefit from early intervention. STEMI-PCI Quality-Reporting Systems and CA Data on outcomes from PCI performed in the setting of an STEMI have been collected, compared, and reported publicly for more than a decade in numerous regional, state, and national databases. The purpose of this public reporting is to monitor the quality of invasive cardiac procedures to assess any

2013 American Heart Association

10. 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January (...) 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

2012 American Heart Association

11. 2012 ACCF/SCAI Expert Consensus Document on Cardiac Catheterization Laboratory Standards Update

-Reporting xxxx 8.4. Informed Consent xxxx 8.5. Ethics of “Teaching” xxxx 8.6. Clinical Research Studies During Diagnostic and Interventional Cardiac Catheterization ..xxxx 8.7. Physician and Physician Group–Industry Relations xxxx 8.8. Hospital Employment of Physicians xxxx 9. X-Ray Imaging xxxx 9.1. Equipment and the “Imaging Chain” xxxx 9.1.1. Image Formation xxxx 9.1.2. Digital Storage and Display xxxx 9.1.3. Quantitative Measures xxxx 9.2. Radiation xxxx 9.2.1. Biological Risks xxxx 9.2.2. Measuring (...) into a therapeutic environment. Technology has changed both the imaging and reporting systems. The lower risk of invasive procedures has seen the expansion of cardiac catheterization laborato- ries to sites without onsite cardiovascular surgery backup and even to community hospitals where primary percutane- ous coronary intervention (PCI) is now being performed. This has increased the importance of quality assurance (QA) and quality improvement (QI) initiatives. At the same time, the laboratory has become

2012 Society for Cardiovascular Angiography and Interventions

12. Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour

Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour Nursing Best Practice Guideline Shaping the Future of Nursing Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour January 2009Greetings from Doris Grinspun Executive Director Registered Nurses’ Association of Ontario It is with great excitement that the Registered Nurses’ Association of Ontario (RNAO) presents this guideline, Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour (...) : Registered Nurses’ Association of Ontario.(2008) Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour. Toronto, Canada. Registered Nurses’ Association of Ontario. Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour Registered Nurses’ Association of Ontario Nursing Best Practice Guidelines Program 158 Pearl Street Toronto, Ontario M5H 1L3 Website: www.rnao.org/bestpracticesElaine Santa Mina (Sta. Mina), RN, BA, BAAN, MSc, PhD, CPMHN(C) Team Leader Associate

2009 Registered Nurses' Association of Ontario

13. Perioperative Cardiac Management

RH. Preoperative cardiac evaluation: mechanisms, assessment, and reduction of risk. Thorac Surg Clin . 2005 May. 15(2):263-75. . Barash PG. Preoperative evaluation of the cardiac patient for noncardiac surgery. Can J Anaesth . 1991 May. 38(4 Pt 2):R134-44. . Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA . 285(14):1865-73. . Eagle KA, Berger PB, Calkins (...) ; the proportion is expected to increase to 25% by 2050. This aging population has associated comorbidities; consequently, clinicians are often asked to evaluate the preoperative risk status of this high-risk population. See algorithm for preoperative cardiac assessment below. Perioperative cardiac management. Algorithm for preoperative cardiac assessment. The cardiovascular systems of patients who undergo and noncardiac surgical procedures are subject to multiple stresses and complications. A previously

2014 eMedicine.com

14. Use of Cardiac Markers in the Emergency Department (Follow-up)

. Cardiac troponin levels in heart failure. Cardiol Rev . 2004 Jan-Feb. 12(1):21-5. . Sandhu R, Aronow WS, Rajdev A, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol . 2008 Sep 1. 102(5):632-4. . Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive (...) processing > Cardiac Markers Updated: Nov 20, 2018 Author: Donald Schreiber, MD, CM; Chief Editor: Barry E Brenner, MD, PhD, FACEP Share Email Print Feedback Close Sections Sections Cardiac Markers Definition and Efficacy Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS). The cardiac troponins, in particular, have become the cardiac markers of choice for patients with ACS. Indeed, cardiac troponin is central

2014 eMedicine Emergency Medicine

15. Use of Cardiac Markers in the Emergency Department (Diagnosis)

. Cardiac troponin levels in heart failure. Cardiol Rev . 2004 Jan-Feb. 12(1):21-5. . Sandhu R, Aronow WS, Rajdev A, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol . 2008 Sep 1. 102(5):632-4. . Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive (...) processing > Cardiac Markers Updated: Nov 20, 2018 Author: Donald Schreiber, MD, CM; Chief Editor: Barry E Brenner, MD, PhD, FACEP Share Email Print Feedback Close Sections Sections Cardiac Markers Definition and Efficacy Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS). The cardiac troponins, in particular, have become the cardiac markers of choice for patients with ACS. Indeed, cardiac troponin is central

2014 eMedicine Emergency Medicine

16. Use of Cardiac Markers in the Emergency Department (Treatment)

. Cardiac troponin levels in heart failure. Cardiol Rev . 2004 Jan-Feb. 12(1):21-5. . Sandhu R, Aronow WS, Rajdev A, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol . 2008 Sep 1. 102(5):632-4. . Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive (...) processing > Cardiac Markers Updated: Nov 20, 2018 Author: Donald Schreiber, MD, CM; Chief Editor: Barry E Brenner, MD, PhD, FACEP Share Email Print Feedback Close Sections Sections Cardiac Markers Definition and Efficacy Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS). The cardiac troponins, in particular, have become the cardiac markers of choice for patients with ACS. Indeed, cardiac troponin is central

2014 eMedicine Emergency Medicine

17. Use of Cardiac Markers in the Emergency Department (Overview)

. Cardiac troponin levels in heart failure. Cardiol Rev . 2004 Jan-Feb. 12(1):21-5. . Sandhu R, Aronow WS, Rajdev A, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol . 2008 Sep 1. 102(5):632-4. . Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive (...) processing > Cardiac Markers Updated: Nov 20, 2018 Author: Donald Schreiber, MD, CM; Chief Editor: Barry E Brenner, MD, PhD, FACEP Share Email Print Feedback Close Sections Sections Cardiac Markers Definition and Efficacy Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS). The cardiac troponins, in particular, have become the cardiac markers of choice for patients with ACS. Indeed, cardiac troponin is central

2014 eMedicine Emergency Medicine

18. Cardiovascular Risk Factors in Central Retinal Artery Occlusion: Results of a Prospective and Standardized Medical Examination. (PubMed)

Cardiovascular Risk Factors in Central Retinal Artery Occlusion: Results of a Prospective and Standardized Medical Examination. To analyze the underlying risk factors in patients with nonarteritic central retinal artery occlusion (CRAO) in a well-defined and homogenous group of patients enrolled in the European Assessment Group for Lysis in the Eye (EAGLE) study.Analysis of the cardiovascular risk factors in a prospective, randomized clinical trial.Seventy-seven EAGLE patients with nonarteritic (...) in their medical history, and comprehensive phenotyping identified at least 1 new risk factor in 60 patients (78%; 95% confidence interval, 67%-87%). Thirty-one (40%) had carotid artery stenosis of at least 70%. Eleven patients experienced a stroke, 5 of those within 4 weeks after the CRAO occurred. Arterial hypertension was found in 56 (73%) patients and was newly diagnosed in 12 (16%) study participants. Cardiac diseases were also highly prevalent (22% coronary artery disease, 20% atrial fibrillation, and 17

2015 Ophthalmology

19. Guidelines on Chronic Coronary Syndromes

test 18 3.1.5.6 Invasive testing 19 3.1.6 Step 6: assess event risk 21 3.1.6.1 Definition of levels of risk 22 3.2 Lifestyle management 23 3.2.1 General management of patients with coronary artery disease 23 3.2.2 Lifestyle modification and control of risk factors 23 3.2.2.1 Smoking 23 3.2.2.2 Diet and alcohol 24 3.2.2.3 Weight management 24 3.2.2.4 Physical activity 24 3.2.2.5 Cardiac rehabilitation 24 3.2.2.6 Psychosocial factors 24 3.2.2.7 Environmental factors 25 3.2.2.8 Sexual activity 25 (...) What is new in the 2019 Guidelines? 8 3. Patients with angina and/or dyspnoea, and suspected coronary artery disease 10 3.1 Basic assessment, diagnosis, and risk assessment 10 3.1.1 Step 1: symptoms and signs 11 3.1.1.1 Stable vs. unstable angina 12 3.1.1.2 Distinction between symptoms caused by epicardial vs. microvascular/vasospastic disease 13 3.1.2 Step 2: comorbidities and other causes of symptoms 13 3.1.3 Step 3: basic testing 13 3.1.3.1 Biochemical tests 13 3.1.3.2 Resting electrocardiogram

Full Text available with Trip Pro

2019 European Society of Cardiology

20. Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD

diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), European Heart Journal , , ehz486, Download citation file: © 2019 Oxford University Press Navbar Search Filter Mobile Microsite Search Term Close search filter search input , , , , , , , , , , , Table of contents Abbreviations and acronyms 4 1 Preamble 6 2 Introduction 8 3 What is new in the 2019 Guidelines? 9 4 Diagnosis of diabetes and pre-diabetes 11 5 Cardiovascular risk assessment (...) in patients with diabetes and pre-diabetes 12 5.1 Diabetes, pre-diabetes, and cardiovascular risk 12 5.2 Stratification of cardiovascular risk in individuals with diabetes 13 5.3 Stratification of cardiovascular risk in individuals with pre-diabetes 13 5.4 Clinical assessment of cardiovascular damage 13 5.4.1 Biomarkers 13 5.4.2 Electrocardiography 14 5.4.3 Imaging techniques 14 6 Prevention of cardiovascular disease in patients with diabetes and pre-diabetes 17 6.1 Lifestyle 17 6.1.1 Diet 17 6.1.1.1

Full Text available with Trip Pro

2019 European Society of Cardiology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>